↓ Skip to main content

Dove Medical Press

Article Metrics

Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK

Overview of attention for article published in Cancer Management and Research, August 2013
Altmetric Badge

Mentioned by

googleplus
1 Google+ user

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
20 Mendeley
Title
Cost-effectiveness of an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer in the UK
Published in
Cancer Management and Research, August 2013
DOI 10.2147/cmar.s44539
Pubmed ID
Authors

Samantha Humphreys, Pellissier, Alison Jones

Abstract

Prevention of chemotherapy-induced nausea and vomiting (CINV) remains an important goal for patients receiving chemotherapy. The objective of this study was to define, from the UK payer perspective, the cost-effectiveness of an antiemetic regimen using aprepitant, a selective neurokinin-1 receptor antagonist, for patients receiving chemotherapy for breast cancer.

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 5%
Unknown 19 95%

Demographic breakdown

Readers by professional status Count As %
Other 5 25%
Researcher 5 25%
Student > Bachelor 3 15%
Student > Doctoral Student 2 10%
Student > Ph. D. Student 2 10%
Other 3 15%
Readers by discipline Count As %
Medicine and Dentistry 9 45%
Agricultural and Biological Sciences 4 20%
Unspecified 3 15%
Economics, Econometrics and Finance 1 5%
Immunology and Microbiology 1 5%
Other 2 10%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 October 2013.
All research outputs
#2,015,838
of 3,629,728 outputs
Outputs from Cancer Management and Research
#51
of 94 outputs
Outputs of similar age
#49,915
of 96,139 outputs
Outputs of similar age from Cancer Management and Research
#2
of 3 outputs
Altmetric has tracked 3,629,728 research outputs across all sources so far. This one is in the 25th percentile – i.e., 25% of other outputs scored the same or lower than it.
So far Altmetric has tracked 94 research outputs from this source. They receive a mean Attention Score of 2.7. This one is in the 17th percentile – i.e., 17% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,139 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.